Bionano Genomics Inc (BNGO)

0.2273 -0.04 (-15.88%) USD  |  NASDAQ  |  Jan 08, 16:00
0.231 0.00 (0.00%) Pre-Market: 09:11
More

Bionano Genomics SG&A Expense (Quarterly): 9.464M for Sept. 30, 2024

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for BNGO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense Definition

View SG&A Expense Definition
Start Trial

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Revvity Inc 239.48M
Bruker Corp 238.50M
Azenta Inc 72.01M
Harvard Bioscience Inc 10.56M
Akoya Biosciences Inc 14.67M